Analytical Method Development and Validation of Capecitabine from Tablet Dosage Form by Using RP-HPLC
Keywords:
Capecitabine, RP-HPLC MethodAbstract
A simple, precise and accurate RP-HPLC method was developed and validated for rapid assay of Capecitabine in tablet dosage form by using a mobile phase consisting mixture of Methanol: Water in the ratio (85:15 % v/v) at the flow rate of 1 mL/min. Symmetry Chromosil C-18 (4.6×250mm), was used as stationary phase. The UV detection wavelength was 303 nm and 10µl sample was injected. The retention time for Capecitabine was 4.2 min. The percentage RSD for precision and accuracy of the method was found to be less than 2%. The method was validated as per the ICH guidelines. The method was successfully applied for routine analysis of Capecitabine in tablet dosage form.
Downloads
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).